Skip to content
Sign in
Public funderBacked 3 network startups

U.S. National Institutes of Health (NIH)

US federal biomedical research agency funding biotech, health and medtech via SBIR and research grants (Defined Bioscience, Microvitality, Corticale).

Bethesda, United States
Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
3
Co-investors
0

How they invest

Biomedical research and commercialisation via R-series and SBIR grants.

Stage and ticket

Non-dilutive grants (e.g., SBIR Phase II $1.5M).

Geography

United States (Corticale shows foreign research grants are possible but SBIR requires US small business).

What makes them say yes

  • Strong science and preliminary data
  • US small business for SBIR
  • Health-outcome relevance

Red flags

  • Weak preliminary data
  • Non-US entity for SBIR

Sectors

  • Biotech & life sciences
  • HealthTech
  • MedTech & devices

Stages

Not published

Geographies

  • United States

How to approach

Apply to the relevant NIH institute's SBIR solicitation; Defined Bioscience can share tips.

Portfolio

3 network startups · no other company

Enabling biotech, diagnostics and neurotech.

Gaps in the portfolio

  • Therapeutics
  • Kidney care

Network startups

  • CorticaleSWC 2026 Finalist

    IIT spin-off selling SiNAPS CMOS neural probes with 1,024 active electrodes for high-density brain recording, an option on brain-computer interfaces.

    Italy · MedTech & devices

  • Defined BioscienceSWC 2026 Finalist

    San Diego maker of fully defined, serum-free stem cell media that lower cost and variability for iPSC research and biomanufacturing.

    United States · Biotech & life sciences

    • SBIR Phase II grant · $1.5MSource
  • MicrovitalitySWC 2026 Finalist

    Tufts spin-off with an IRB-approved ingestible capsule that samples small-intestine microbiome and contents non-invasively.

    United States · MedTech & devices

    • research grant (NIH R21/R33)Source

Network startups that fit

5 analysed

Preclinical biotech licensing University of Miami RNA aptamers to regenerate beta cells in type 1 diabetes and target solid tumours.

US RNA aptamers for type 1 diabetes and tumours — NIDDK/NCI fit.

50%confidence

Evidence from the records

  • “"Biotech & life sciences"”
  • “RNA aptamers – type 1 diabetes and solid tumors”
  • “No public evidence of traction found: preclinical RNA aptamer pipeline.”
Intro path
Founder-to-founder intro via Corticale, Defined Bioscience, Microvitality (network portfolio company of U.S. National Institutes of Health (NIH)).
First step
Prepare SBIR Phase I.

FDA-cleared low-cost automated peritoneal dialysis cycler, built in a DRAP-approved Pakistani factory, preparing first US patients.

US at-home peritoneal dialysis — kidney disease medtech.

45%confidence

Evidence from the records

  • “"MedTech & devices"”
  • “At-home peritoneal dialysis”
  • “X-1 APD cycler and DS-1 set: FDA 510(k) clearance K243371 (decision of 16 May 2025, class II)”
Intro path
Founder-to-founder intro via Corticale, Defined Bioscience, Microvitality (network portfolio company of U.S. National Institutes of Health (NIH)).
First step
Apply to NIDDK SBIR.

Nurse-practitioner-founded device start-up designing a multi-drug emergency IV pump with protocol-guided dosing safeguards.

US emergency multi-drug IV pump.

40%confidence

Evidence from the records

  • “MedTech & devices”
  • “Multi-drug emergency IV pump”
  • “No public evidence of traction found: pump shown as a concept visual”
Intro path
Founder-to-founder intro via Corticale, Defined Bioscience, Microvitality (network portfolio company of U.S. National Institutes of Health (NIH)).
First step
Apply SBIR.

Smartphone eyelid-photo AI that screens for anemia in seconds without a blood draw, aimed at low-resource care.

US AI anemia detection.

35%confidence

Evidence from the records

  • “"HealthTech"”
  • “AI anemia detection”
  • “NiADA app (analysis of a smartphone photo of the lower eyelid) available on Google Play and Apple TestFlight”
Intro path
Founder-to-founder intro via Corticale, Defined Bioscience, Microvitality (network portfolio company of U.S. National Institutes of Health (NIH)).
First step
Apply SBIR.

Physician-led Kansas medtech developing UniPen, a universal vial-compatible self-injection pen aimed at cutting pharma device costs and lead times.

US self-injection devices.

30%confidence

Evidence from the records

  • “MedTech & devices”
  • “Self-injection devices”
  • “UniPen available through licensed pharmacies (not FDA-authorized)”
Intro path
Founder-to-founder intro via Corticale, Defined Bioscience, Microvitality (network portfolio company of U.S. National Institutes of Health (NIH)).
First step
Apply SBIR.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

No co-investment documented yet.

Sources